oneok partners lp (OKS:New York)
Gil J. Van Lunsen
Director of Oneok Partners GP LLC, Chairman of Audit Committee and Chairman of Conflicts Committee, ONEOK Partners, L.P.
|Age||Total Calculated Compensation||This person is connected to 27 board members in 5 different organizations across 6 different industries.|
See Board Relationships
Mr. Gil J. Van Lunsen served as a Managing Partner of KPMG LLP and led its Tulsa, Oklahoma office, since 1994. Mr. Van Lunsen retired from KPMG LLP in June 2000 following 32 years of service. Nine years after joining KPMG in 1968 as an Assistant Accountant, he became Partner and subsequently was promoted to Partner in charge of national accounting and audit training. He transferred to the Tulsa Oklahoma office in July 1980. He served as chairman of the board of trustees ...
100 West Fifth StreetPhone: 918-588-7000
Tulsa, Oklahoma 74103
Board Members Memberships*
Director, Chairman of Audit Committee and Member of Corporate Governance Committee
Former Director, Chairman of Audit Committee and Member of Nominating Committee
Director of Oneok Partners GP LLC, Chairman of Audit Committee and Chairman of Conflicts Committee
Independent Director, Chairman of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee
University of Denver
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer|
|€601.0K||Compensation as of Fiscal Year 2013.|